Live Breaking News & Updates on Regular Market Approval

Stay updated with breaking news from Regular market approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Covishield, Covaxin get regular market approval for use in adult population

India s drug regulator on Thursday granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, official sources said. The approval was granted under the New Drugs and Clinical Trials Rules, 2019. Under the conditions, the firms shall submit data of ongoing clinical trials and the vaccines to be supplied for programmatic setting. Adverse event following immunisation will continue to be monitored. The Drugs Controller ....

V Krishna Mohan , Prakash Kumar Singh , Regulatory Affairs , Bharat Biotech International Limited , Serum Institute Of India , Expert Committee , Central Drugs Standard Control Organisation , Image Source , Drugs Controller General , Subject Expert Committee , Serum Institute , Bharat Biotech , New Drugs , Clinical Trials Rules , Kumar Singh , Hyderabad Based Bharat Biotech , Biotech International Limited , Covishield Price , Covaxin Price , Regular Market Approval , Vaccination In India , Covid Vaccination In India ,